4.3 Article

Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val

Related references

Note: Only part of the references are listed.
Letter Clinical Neurology

Mutation analysis of CHCHD10 in different neurodegenerative diseases

Ming Zhang et al.

BRAIN (2015)

Article Geriatrics & Gerontology

CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients

Adriano Chio et al.

NEUROBIOLOGY OF AGING (2015)

Article Clinical Neurology

Late Onset Spinal Motor Neuronopathy Is Caused by Mutation in CHCHD10

Sini Penttila et al.

ANNALS OF NEUROLOGY (2015)

Article Genetics & Heredity

CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease

Mari Auranen et al.

NEUROLOGY-GENETICS (2015)

Article Biochemistry & Molecular Biology

Targeted next-generation sequencing reveals further genetic heterogeneity in axonal Charcot-Marie-Tooth neuropathy and a mutation in HSPB1

Emil Ylikallio et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2014)

Article Clinical Neurology

Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion

Stefan Vielhaber et al.

ACTA NEUROPATHOLOGICA (2013)

Article Biochemistry & Molecular Biology

Autosomal dominant late-onset spinal motor neuronopathy is linked to a new locus on chromosome 22q11.2-q13.2

Sini Penttila et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2012)

Article Biochemistry & Molecular Biology

Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons

Seungmin Lee et al.

HUMAN MOLECULAR GENETICS (2012)

Article Clinical Neurology

Late-onset lower motor neuronopathy A new autosomal dominant disorder

M. Jokela et al.

NEUROLOGY (2011)

Article Clinical Neurology

Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2

S Züchner et al.

ANNALS OF NEUROLOGY (2006)